quinazolines has been researched along with Hantavirus Pulmonary Syndrome in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brocato, RL; Hooper, JW | 1 |
| Bird, BH; Dodd, KA; Erickson, BR; Shrivastava-Ranjan, P; Spiropoulou, CF | 1 |
| Dolgin, E | 1 |
1 review(s) available for quinazolines and Hantavirus Pulmonary Syndrome
| Article | Year |
|---|---|
Progress on the Prevention and Treatment of Hantavirus Disease.
Topics: Adrenal Cortex Hormones; Amides; Animals; Antiviral Agents; Clinical Trials as Topic; Hantavirus Infections; Hantavirus Pulmonary Syndrome; Hemorrhagic Fever with Renal Syndrome; Humans; Immunotherapy; Lactoferrin; Models, Animal; Nucleosides; Orthohantavirus; Piperidines; Pyrazines; Quinazolines; Recombinant Proteins; Ribavirin; Triazoles; Vaccines, Synthetic; Viral Vaccines | 2019 |
2 other study(ies) available for quinazolines and Hantavirus Pulmonary Syndrome
| Article | Year |
|---|---|
Effect of Vandetanib on Andes virus survival in the hamster model of Hantavirus pulmonary syndrome.
Topics: Animals; Capillary Permeability; Cricetinae; Disease Models, Animal; Endothelial Cells; Hantavirus Pulmonary Syndrome; Orthohantavirus; Phosphorylation; Piperidines; Protein Kinase Inhibitors; Quinazolines; Vascular Endothelial Growth Factor A; Viral Load | 2016 |
Hantavirus treatments advance amidst outbreak in US park.
Topics: Animals; California; Cricetinae; Disease Models, Animal; Disease Outbreaks; Hantavirus Pulmonary Syndrome; Humans; Mesocricetus; Orthohantavirus; Piperidines; Quinazolines; Receptors, Vascular Endothelial Growth Factor; United States; Viral Vaccines | 2012 |